Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban--an oral, direct factor Xa inhibitor--are not affected by aspirin - Kubitza, D; Becka, M; Mueck, W; Zuehlsdorf, M (J Clin Pharmacol, 2006)